Friday, October 27, 2023

 

Medication abortion safety and effectiveness with misoprostol alone

JAMA Network Open

Peer-Reviewed Publication

JAMA NETWORK




About The Study: The findings in this study of 637 callers to safe abortion hotlines and accompaniment groups in Argentina, Nigeria, and Southeast Asia suggest that misoprostol alone is a highly effective method of pregnancy termination. Future research should explore strategies to maximize the effectiveness of misoprostol alone in clinical and nonclinical settings. 

Authors: Ruvani Jayaweera, Ph.D., of Ibis Reproductive Health in Oakland, California, is the corresponding author. 

 To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.40042)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article 

 http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.40042?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102723

No comments: